These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 14727553)
1. [A case of malignant lymphoma associated with diffuse pulmonary involvement successfully treated with rituximab]. Kataoka T; Ishida Y; Kurokawa R; Takeshita S; Ohta K; Nishimura Y; Yokoyama M Nihon Kokyuki Gakkai Zasshi; 2003 Dec; 41(12):899-904. PubMed ID: 14727553 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related]
3. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature. Alvaro-Naranjo T; Jaén-Martínez J; Gumá-Padró J; Bosch-Príncep R; Salvadó-Usach MT Ann Hematol; 2003 Sep; 82(9):585-8. PubMed ID: 12898184 [TBL] [Abstract][Full Text] [Related]
4. What is the role of maintenance rituximab in follicular NHL? Maloney DG Oncology (Williston Park); 2008 Jan; 22(1):20-6; discussion 26, 29, 33-4. PubMed ID: 18251281 [TBL] [Abstract][Full Text] [Related]
5. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail]. Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785 [TBL] [Abstract][Full Text] [Related]
6. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy]. Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050 [TBL] [Abstract][Full Text] [Related]
7. The therapeutic use of rituximab in non-Hodgkin's lymphoma. Marcus R; Hagenbeek A Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982 [TBL] [Abstract][Full Text] [Related]
9. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy? Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V; Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of rituximab plus chemotherapy in follicular lymphoma depends on Ki-67 expression. Saito B; Shiozawa E; Yamochi-Onizuka T; Adachi D; Nakamaki T; Tomoyasu S; Omine M; Mitsuya T; Takimoto M; Ota H Pathol Int; 2004 Sep; 54(9):667-74. PubMed ID: 15363034 [TBL] [Abstract][Full Text] [Related]
11. Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma. Boland A; Bagust A; Hockenhull J; Davis H; Chu P; Dickson R Health Technol Assess; 2009 Sep; 13 Suppl 2():41-8. PubMed ID: 19804688 [TBL] [Abstract][Full Text] [Related]
12. Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment Group. Witzig TE; Vukov AM; Habermann TM; Geyer S; Kurtin PJ; Friedenberg WR; White WL; Chalchal HI; Flynn PJ; Fitch TR; Welker DA J Clin Oncol; 2005 Feb; 23(6):1103-8. PubMed ID: 15657404 [TBL] [Abstract][Full Text] [Related]
13. Anti-CD20 monoclonal antibody (Rituximab) for therapy of mediastinal CD20-positive large B-cell non-Hodgkin lymphoma with a local tumor extension into the lung of a 10-year-old girl. Culić S; Culić V; Armanda V; Kuljis D; Pesutić-Pisac V; Janković S Pediatr Hematol Oncol; 2003 Jun; 20(4):339-44. PubMed ID: 12746167 [TBL] [Abstract][Full Text] [Related]
14. [Use of Mabtera (rituximab) in treating patients with refractory courses of B-cell lymphoma, along with high-dose chemotherapy and autologous transplantation of hematopoietic stem cells]. Ptushkin VV; Chimishkian KL; Zhukov NV; Osmanov DSh; Andreeva LIu; Tupitsyn NN; Larionova VB; Mkheidze DM; Poddubnaia NV Ter Arkh; 2003; 75(1):65-8. PubMed ID: 12652962 [TBL] [Abstract][Full Text] [Related]
15. An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy. Mishima Y; Sugimura N; Matsumoto-Mishima Y; Terui Y; Takeuchi K; Asai S; Ennishi D; Asai H; Yokoyama M; Kojima K; Hatake K Clin Cancer Res; 2009 May; 15(10):3624-32. PubMed ID: 19417028 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma]. Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800 [TBL] [Abstract][Full Text] [Related]
17. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Grillo-López AJ; White CA; Varns C; Shen D; Wei A; McClure A; Dallaire BK Semin Oncol; 1999 Oct; 26(5 Suppl 14):66-73. PubMed ID: 10561020 [TBL] [Abstract][Full Text] [Related]
18. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab]. Al-Ali HK; Wittekind C; Niederwieser D Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864 [TBL] [Abstract][Full Text] [Related]
19. Rituximab and other emerging antibodies as molecular target-based therapy of lymphoma. Tobinai K Int J Clin Oncol; 2003 Aug; 8(4):212-23. PubMed ID: 12955576 [TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma]. Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]